ACSL1 is associated with fetal programming of insulin sensitivity and cellular lipid content

Molecular Endocrinology

Volumn 29, Issue 6, 2015, Pages 909-920

  Joseph, Roy ^a   Poschmann, Jeremie ^b   Sukarieh, Rami ^a   Too, Peh Gek ^a   Julien, Sofi G ^a   Xu, Feng ^a   The, Ai Ling ^a   Holbrook, Joanna D ^a   Ng, Kai Lyn ^c   Chong, Yap Seng ^a,c   Gluckman, Peter D ^a,d   Prabhakar, Shyam ^b   Stünkel, Walter ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A SYNTHETASE 1; LONG CHAIN FATTY ACID COENZYME A LIGASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACSL1 PROTEIN, HUMAN; ACSL1 PROTEIN, MOUSE; COENZYME A LIGASE; CYTOKINE; GLUCOSE; HISTONE; INSULIN; LYSINE;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FOOD INTAKE; GENE EXPRESSION; GLUCOSE TRANSPORT; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; MALE; MESENCHYMAL STEM CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SMALL FOR DATE INFANT; UPREGULATION; WHARTON JELLY; ACETYLATION; ADIPOGENESIS; ANIMAL; CELL CULTURE; CYTOLOGY; DNA MICROARRAY; FETUS DEVELOPMENT; GENE SILENCING; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE MUTANT;

MUS;

ACETYLATION; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; COENZYME A LIGASES; CYTOKINES; EPIGENESIS, GENETIC; FETAL DEVELOPMENT; GENE KNOCKDOWN TECHNIQUES; GENETIC ASSOCIATION STUDIES; GLUCOSE; HISTONES; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; LIPID METABOLISM; LYSINE; MESENCHYMAL STROMAL CELLS; MICE, OBESE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84930826730     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1020     Document Type: Article

References (43)

1. Gluckman PD, Hanson MA. Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med. 2004;9:419–425.
2. Gluckman PD, Hanson MA. The consequences of being born small -an adaptive perspective. Horm Res. 2006;65(suppl 3):5–14.
3. Godfrey KM, Barker DJ. Fetal programming and adult health. Public Health Nutr. 2001;4:611–624.
4. Belkacemi L, Nelson DM, Desai M, Ross MG. Maternal undernu-trition influences placental-fetal development. Biol Reprod. 2010; 83:325–331.
5. Gluckman PD, Hanson MA, Spencer HG, Bateson P. Environmental influences during development and their later consequences for health and disease: implications for the interpretation of empirical studies. Proc Biol Sci. 2005;272:671–677.
6. Berends LM, Fernandez-Twinn DS, Martin-Gronert MS, Cripps RL, Ozanne SE. Catch-up growth following intra-uterine growth-restriction programmes an insulin-resistant phenotype in adipose tissue. Int J Obes. 2013;37:1051–1057.
7. Varvarigou AA. Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J Pediatr Endocrinol Metab. 2010;23:215–224.
8. Ross MG, Desai M. Developmental programming of appetite/satiety. Ann Nutr Metab. 2014;64:36–44.
9. Dunlop K, Cedrone M, Staples JF, Regnault TR. Altered fetal skeletal muscle nutrient metabolism following an adverse in utero environment and the modulation of later life insulin sensitivity. Nutrients. 2015;7:1202–1216.
10. Peñagaricano F, Wang X, Rosa GJ, Radunz AE, Khatib H. Maternal nutrition induces gene expression changes in fetal muscle and adipose tissues in sheep. BMC Genomics. 2014;15:1034.
11. Ruan H, Lodish HF. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines. Curr Opin Lipidol. 2004;15:297–302.
12. Gluckman PD, Hanson MA, Low FM. The role of developmental plasticity and epigenetics in human health. Birth Defects Res C Embryo Today. 2011;93:12–18.
13. Ross MG, Desai M. Developmental programming of offspring obesity, adipogenesis, and appetite. Clin Obstet Gynecol. 2013;56: 529–536.
14. Desai M, Beall M, Ross MG. Developmental origins of obesity: programmed adipogenesis. Curr Diab Rep. 2013;13:27–33.
15. Iaffaldano L, Nardelli C, Raia M, et al. High aminopeptidase N/CD13 levels characterize human amniotic mesenchymal stem cells and drive their increased adipogenic potential in obese women. Stem Cells Dev. 2013;22:2287–2297.
16. Sukarieh R, Joseph R, Leow SC, et al. Molecular pathways reflecting poor intrauterine growth are found in Wharton’s jelly-derived mesenchymal stem cells. Hum Reprod. 2014;29:2287–2301.
17. Mericq V, Ong KK, Bazaes R, et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia. 2005;48: 2609–2614.
18. Fong CY, Subramanian A, Biswas A, et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton’s jelly stem cells. Reprod Biomed. 2010;21:391–401.
19. Quail MA, Kozarewa I, Smith F, et al. A large genome center’s improvements to the Illumina sequencing system. Nat Methods. 2008;5:1005–1010.
20. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–1760.
21. Zhang Y, Liu T, Meyer CA, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.
22. Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38: 576–589.
23. Kumar V, Muratani M, Rayan NA, et al. Uniform, optimal signal processing of mapped deep-sequencing data. Nat Biotechnol. 2013; 31:615–622.
24. Julien SG, Dubé N, Read M, et al. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumori-genesis and protects from lung metastasis. Nat Genet. 2007;39(3): 338–346.
25. Tosh DN, Fu Q, Callaway CW, et al. Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal catch-up growth. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1023-G1029.
26. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57-74.
27. Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011;473:43-49.
28. Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev. 2014;94:1027-1076.
29. Bateson P, Gluckman P, Hanson M. The biology of developmental plasticity and the predictive adaptive response hypothesis. J Physiol. 2014;592:2357-2368.
30. Schultz NS, Broholm C, Gillberg L, et al. Impaired leptin gene expression and release in cultured preadipocytes isolated from individuals born with low birth weight. Diabetes. 2014;63:111-121.
31. Soupene E, Kuypers FA. Mammalian long-chain acyl-CoA synthetases. Exp Biol Med (Maywood). 2008;233:507-521.
32. Kanter JE, Bornfeldt KE. Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. Trends Endocrinol Metab. 2013;3:137-144.
33. Zhan T, Poppelreuther M, Ehehalt R, Füllekrug J. Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 increase the cellular fatty acid uptake of 3T3-L1 adipocytes but are localized on intracellular membranes. PLoS One. 2012;7:e45087.
34. Lobo S, Wiczer BM, Bernlohr DA. Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes. J Biol Chem. 2009;284:18347-18356.
35. Thompson BR, Lobo S, Bernlohr DA. Fatty acid flux in adipocytes: the in’s and out’s of fat cell lipid trafficking. Mol Cell Endocrinol. 2010;318:24-33.
36. Ellis JM, Li LO, Wu PC, et al. Adipose acyl-CoA synthetase-1 directs fatty acids toward /3-oxidation and is required for cold ther-mogenesis. Cell Metab. 2010;12:53-64.
37. Yee JK, Lee WN, Ross MG, et al. Peroxisome proliferator-activated receptor y modulation and lipogenic response in adipocytes of small-for-gestational age offspring. Nutr Metab (Lond). 2012;9:62.
38. Bazaes RA, SalazarTE, Pittaluga E, et al. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics. 2003;111:804-809.
39. Kabir SM, Lee ES, Son DS. Chemokine network during adipogen-esis in 3T3-L1 cells: differential response between growth and proinflammatory factor in preadipocytes vs. adipocytes. Adipocyte. 2014;3:97-106.
40. Park BS, Lee JO. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med. 2013;45:e66.
41. Young JL, Mora A, Cerny A, et al. CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone. PLoS One. 2012; 7:e29688.
42. Nguyen A, Tao H, Metrione M, Hajri T. Very low density lipoprotein receptor (VLDLR) expression is a determinant factor in adipose tissue inflammation and adipocyte-macrophage interaction. J Biol Chem. 2014;289:1688-1703.
43. Cheong CY, Chng K, Lim MK, et al. Alterations to DNA methyl-ation and expression of CXCL14 are associated with suboptimal birth outcomes. J Hum Genet. 2014;59:504-511.